Search Results - "Gallach Garcia, S."

CD5 and CD6: Evaluation of their role as prognostic biomarkers in resectable non-small cell lung cancer by Moreno, A., Calabuig Fariñas, S., Gallach Garcia, S., Fernando, A., Simoes, I., Carreras, E., Consuegra-Fernández, M., Blasco Cordellat, A., Cunquero Tomas, A.J., Martorell, M., Camps, C., Lozano, F., Sirera Perez, R., Jantus-Lewintre, E.

Get full text

Soluble immune biomarkers to anti-PD1 treatment in non-small cell lung cancer (NSCLC) by Garde-Noguera, J., Jantus-Lewintre, E., Honrubia Peris, B., Gallach Garcia, S., Zhang, F., García Sánchez, J., Calabuig Fariñas, S., Blasco Cordellat, A., Piera Molons, N., Vidal-Martinez, J., Murado-Pardo, J., Condori Farfan, L.D., Gisbert-Criado, R., Escorihuela, E., Camps, C.

Get full text

219P Multicentric evaluation of amplicon-based next-generation sequencing solution for local comprehensive molecular tumor profiling by Jantus Lewintre, E., Rappa, A., Ruano, D., Gallach Garcia, S., Camps Herrero, C.J.C., Lacroix, L., Kashofer, K., van Wezel, T., Barberis, M.

Get full text

773P Real-world results of homologous recombination deficiency testing: Comparison between two methods on 2,655 ovarian cancer patients in Spain by Lazaro, C., Jantus Lewintre, E., Zazo, S., Pérez, S., Carvajal Garcia, N., Azuara, D., González Acosta, M., Varela, M., Torres-Martínez, S., Gallach Garcia, S., Colomar, M., Sanchez Ares, M., Perez-Becerra, R., Antunez, J.R., Orellana, M., Lencina, M., Abdulkader Nallib, I., Camps Herrero, C.J.C., Matias-Guiu, X., Rojo, F.

Get full text

1196P Identification of targetable alterations using NGS-based liquid biopsy in NSCLC patients by Moreno-Manuel, A., Gallach Garcia, S., Calabuig-Fariñas, S., Blasco Cordellat, A., Ferrero Gimeno, M., Ruiz Cordero, V., Torres Martinez, S., Duréndez, E., Mosqueda, M., Escorihuela, E., Fernandez Diaz, A., Aparisi Aparisi, F.D.A., Jantus Lewintre, E., Camps, C.

Get full text

Prognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy by Calabuig-Fariñas, S., Muinelo-Romay, L., Abalo, A., Lago, R., Mosqueda, M., Rodriguez Lopez, C., Escorihuela, E., Gallach Garcia, S., Garcia, J., Blasco, A., Jantus-Lewintre, E., López, R., Camps, C.

Get full text

1923P - Prognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy by Calabuig-Fariñas, S., Muinelo-Romay, L., Abalo, A., Lago, R., Mosqueda, M., Rodriguez Lopez, C., Escorihuela, E., Gallach Garcia, S., Garcia, J., Blasco, A., Jantus-Lewintre, E., López, R., Camps, C.

“…Lung cancer is the leading cause of cancer-related mortality worldwide. At diagnosis, 70% of patients present advanced disease being chemotherapy the standard…”
Get full text

1923PPrognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy by Calabuig-Fariñas, S, Muinelo-Romay, L, Abalo, A, Lago, R, Mosqueda, M, Rodriguez Lopez, C, Escorihuela, E, Gallach Garcia, S, Garcia, J, Blasco, A, Jantus-Lewintre, E, López, R, Camps, C

“…Abstract Background Lung cancer is the leading cause of cancer-related mortality worldwide. At diagnosis, 70% of patients present advanced disease being…”
Get full text

1212P Exosomes cargo analysis as an approach to identify new biomarkers in NSCLC by Duréndez Sáez, E., Calabuig-Fariñas, S., Suarez, C., Ferrero Gimeno, M., Mosqueda, M., Moreno, A., Torres Martinez, S., Hererros-Pomares, A., Gallach Garcia, S., Nunez Abad, M., Blasco Cordellat, A., Aparisi Aparisi, F.D.A., Serna, E., Paramio, J.M., Jantus Lewintre, E., Camps, C.

Get full text

1039P Analysis of predictive and prognostic soluble biomarkers in advanced non-small cell lung cancer (NSCLC) patients treated with anti-PD1/PDL1 by Garcia, S. Gallach, Noguera, J. Garde, Martinez, S. Torres, Aparisi, F.D.A. Aparisi, Martínez, J. Vidal, Escorihuela, E., Criado, R. Gisbert, Moreno, A., Gimeno, M. Ferrero, Abad, M. Meri, Shaheen, I., Calabuig-Fariñas, S., Cordellat, A. Blasco, Peris, B. Honrubia, Sánchez, J. García, Lewintre, E. Jantus, Camps, C.

Get full text

Next Generation Sequencing in Liquid Biopsies: Towards Personalized Cancer Treatment by Garcia, S. Gallach, Mosqueda, M., Moreno-Manuel, A., Navarro, L., Torres-Martínez, S., Munera-Maravilla, E., Blasco, A., Calabuig-Fariñas, S., Camps, C., Jantus-Lewintre, E.

Get full text

Stemness characterization of tumorspheres from non-small cell lung cancer: Differential expression in CSC-related markers and signaling pathways by Herreros Pomares, A., Calabuig Fariñas, S., Escorihuela, E., Amado, H., Guijarro, R., Gallach Garcia, S., Navarro, A., Jantus-Lewintre, E., Camps Herrero, C.

Get full text

1855PCD5 and CD6: Evaluation of their role as prognostic biomarkers in resectable non-small cell lung cancer by Moreno, A, Calabuig Fariñas, S, Gallach Garcia, S, Fernando, A, Simoes, I, Carreras, E, Consuegra-Fernández, M, Blasco Cordellat, A, Cunquero Tomas, A J, Martorell, M, Camps, C, Lozano, F, Sirera Perez, R, Jantus-Lewintre, E

Get full text

Analysis of immunoregulatory biomarkers in early stages of non-small cell lung cancer by Moreno Manuel, A., Calabuig Fariñas, S., Herreros Pomares, A., Gallach Garcia, S., Aranda, F., Blasco, A., Carreras, E., Lozano, F., Cunquero Tomas, A., Martorell, M., Jantus-Lewintre, E., Camps Herrero, C.

Get full text

1420PSoluble immune biomarkers to anti-PD1 treatment in non-small cell lung cancer (NSCLC) by Garde-Noguera, J, Jantus-Lewintre, E, Honrubia Peris, B, Gallach Garcia, S, Zhang, F, García Sánchez, J, Calabuig Fariñas, S, Blasco Cordellat, A, Piera Molons, N, Vidal-Martinez, J, Murado-Pardo, J, Condori Farfan, L D, Gisbert-Criado, R, Escorihuela, E, Camps, C

Get full text

Prognostic Impact of Vegfa in Resectable Non-Small-Cell Lung Cancer by Calabuig Fariñas, S., Jantus-Lewintre, E., Usó, M., Gallach Garcia, S., Sirera Perez, R., Blasco, A., Camps, C.

Get full text

1189PPROGNOSTIC IMPACT OF VEGFA IN RESECTABLE NON-SMALL-CELL LUNG CANCER by Calabuig Fariñas, S., Jantus-Lewintre, E., Usó, M., Gallach Garcia, S., Sirera Perez, R., Blasco, A., Camps, C.

“…Abstract Aim: Angiogenesis is a main process which happens in tumors and that promotes its growth, invasive capacity and metastasis. Host genetic variability…”
Get full text